Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897777 · ClinicalTrials.gov registry record · NA

Exercise, Hypertension, and Gut Dysbiosis in African Americans

A NA study of Hypertension, sponsored by North Carolina Agriculture & Technical State University.

Active
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT03897777: Active NA study of Hypertension, sponsored by North Carolina Agriculture & Technical State University.

NCT03897777 is a NA study of Hypertension that is active but no longer recruiting, run by North Carolina Agriculture & Technical State University. The registered enrollment target is 36 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03897777, a NA study of Hypertension, is active but no longer recruiting, sponsored by North Carolina Agriculture & Technical State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

African Americans have the greatest burden of endothelial dysfunction and hypertension. Recently, gut microbial dysbiosis (a term that describes a poorly diverse gut microbial profile and lower short-chain fatty acid (SCFA) production) has been linked to hypertension and may be involved in the pathogenesis of hypertension in African Americans. African Americans have been reported to have lower gut SCFA and SCFA can reduce blood pressure. Exercise reduces blood pressure and improves gut dysbiosis (increases SCFA) and likely couples' improvements in gut microbial health and vascular function to reduce blood pressure. Thus, the goals of this research are to fill a critical void concerning the interaction of gut dysbiosis, hypertension, and utilizing exercise to identify gut microbial adaptations that accompany a reduction in blood pressure. The short-term implications of this work will advance the clinical communities understanding of the relationship between dysbiosis and the pathogenesis of hypertension in African Americans, while long term implications will promote identifying adaptable gut microbes associated with vascular health to aid in amending treatment strategies for hypertension.

Primary Outcome

Expect a change in systolic and diastolic BP

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Training effect on Hypertension and Gut Dysbiosis

Study Locations (1)

North Carolina

  • North Carolina A&T State University - Greensboro

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2019-06-01
Est. Completion 2026-06
Phase NA

What the registry record for NCT03897777 still lists

NCT03897777 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Exercise Training effect on Hypertension and Gut Dysbiosis is the first listed.

NCT03897777 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03897777 about?

NCT03897777 is a clinical study titled "Exercise, Hypertension, and Gut Dysbiosis in African Americans". African Americans have the greatest burden of endothelial dysfunction and hypertension. Recently, gut microbial dysbiosis (a term that describes a poorly diverse gut microbial profile and lower short-chain fatty acid (SCFA) production) has been linked to hypertension and may be involved in the patho...

What is the current status of trial NCT03897777?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2019-06-01. Estimated completion is 2026-06.

What conditions does trial NCT03897777 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03897777?

The interventions under investigation include: Exercise Training effect on Hypertension and Gut Dysbiosis (BEHAVIORAL).

Who is sponsoring clinical trial NCT03897777?

This trial is sponsored by North Carolina Agriculture & Technical State University, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03897777 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03897777's enrollment target sits among peer trials

36 398th of 470 higher than 70 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03897777, the US trial registry maintained by the National Library of Medicine. NCT03897777 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.